Article Text
Original Article
Embryonic stem cell production through therapeutic cloning has fewer ethical problems than stem cell harvest from surplus IVF embryos
Abstract
Restrictions on research on therapeutic cloning are questionable as they inhibit the development of a technique which holds promise for succesful application of pluripotent stem cells in clinical treatment of severe diseases. It is argued in this article that the ethical concerns are less problematic using therapeutic cloning compared with using fertilised eggs as the source for stem cells. The moral status of an enucleated egg cell transplanted with a somatic cell nucleus is found to be more clearly not equivalent to that of a human being. Based on ethical considerations alone, research into therapeutic cloning should be encouraged in order to develop therapeutic applications of stem cells.
- Cloning
- stem cells
- embryo status
- human emergence
Statistics from Altmetric.com
Footnotes
Read the full text or download the PDF:
Other content recommended for you
- Is a consensus possible on stem cell research? Moral and political obstacles
- Artificial gametes: new paths to parenthood?
- The significance of induced pluripotent stem cells for basic research and clinical therapy
- Reproductive and therapeutic cloning, germline therapy, and purchase of gametes and embryos: comments on Canadian legislation governing reproduction technologies
- Reproductive cloning in humans and therapeutic cloning in primates: is the ethical debate catching up with the recent scientific advances?
- Why the apparent haste to clone humans?
- What’s in a name? Embryos, entities, and ANTities in the stem cell debate
- A natural stem cell therapy? How novel findings and biotechnology clarify the ethics of stem cell research
- The “future like ours” argument and human embryonic stem cell research
- What happened to the stem cells?